Sage Pretax Profit Margin from 2010 to 2024
| SAGE Stock | USD 14.00 1.05 8.11% |
Pretax Profit Margin | First Reported 2010-12-31 | Previous Quarter (6.26) | Current Value (6.58) | Quarterly Volatility 32.17948953 |
Check Sage Therapeutic financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sage main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.3 M, Interest Expense of 17.1 M or Selling General Administrative of 144.2 M, as well as many exotic indicators such as Price To Sales Ratio of 14.25, Dividend Yield of 0.0012 or PTB Ratio of 1.7. Sage financial statements analysis is a perfect complement when working with Sage Therapeutic Valuation or Volatility modules.
Sage | Pretax Profit Margin |
Latest Sage Therapeutic's Pretax Profit Margin Growth Pattern
Below is the plot of the Pretax Profit Margin of Sage Therapeutic over the last few years. It is Sage Therapeutic's Pretax Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sage Therapeutic's overall financial position and show how it may be relating to other accounts over time.
| Pretax Profit Margin | 10 Years Trend |
|
Pretax Profit Margin |
| Timeline |
Sage Pretax Profit Margin Regression Statistics
| Arithmetic Mean | (19.36) | |
| Geometric Mean | 6.91 | |
| Coefficient Of Variation | (166.20) | |
| Mean Deviation | 24.38 | |
| Median | (4.13) | |
| Standard Deviation | 32.18 | |
| Sample Variance | 1,036 | |
| Range | 99.5885 | |
| R-Value | (0.40) | |
| Mean Square Error | 936.92 | |
| R-Squared | 0.16 | |
| Significance | 0.14 | |
| Slope | (2.88) | |
| Total Sum of Squares | 14,497 |
Sage Pretax Profit Margin History
About Sage Therapeutic Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Sage Therapeutic income statement, its balance sheet, and the statement of cash flows. Sage Therapeutic investors use historical funamental indicators, such as Sage Therapeutic's Pretax Profit Margin, to determine how well the company is positioned to perform in the future. Although Sage Therapeutic investors may use each financial statement separately, they are all related. The changes in Sage Therapeutic's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Sage Therapeutic's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Sage Therapeutic Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Sage Therapeutic. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (6.26) | (6.58) |
Currently Active Assets on Macroaxis
When determining whether Sage Therapeutic is a strong investment it is important to analyze Sage Therapeutic's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Sage Therapeutic's future performance. For an informed investment choice regarding Sage Stock, refer to the following important reports:Check out the analysis of Sage Therapeutic Correlation against competitors. For information on how to trade Sage Stock refer to our How to Trade Sage Stock guide.Note that the Sage Therapeutic information on this page should be used as a complementary analysis to other Sage Therapeutic's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for Sage Stock analysis
When running Sage Therapeutic's price analysis, check to measure Sage Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sage Therapeutic is operating at the current time. Most of Sage Therapeutic's value examination focuses on studying past and present price action to predict the probability of Sage Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sage Therapeutic's price. Additionally, you may evaluate how the addition of Sage Therapeutic to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Sage Therapeutic's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sage Therapeutic. If investors know Sage will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sage Therapeutic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (9.05) | Revenue Per Share 1.445 | Quarterly Revenue Growth 26.215 | Return On Assets (0.31) | Return On Equity (0.53) |
The market value of Sage Therapeutic is measured differently than its book value, which is the value of Sage that is recorded on the company's balance sheet. Investors also form their own opinion of Sage Therapeutic's value that differs from its market value or its book value, called intrinsic value, which is Sage Therapeutic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sage Therapeutic's market value can be influenced by many factors that don't directly affect Sage Therapeutic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sage Therapeutic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sage Therapeutic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sage Therapeutic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.